Skip to main content
Premium Trial:

Request an Annual Quote

Letting Them in the House for Your Health

Intel and GE are teaming up to develop and sell home-based healthcare technology and plan to spend $250 million on research and development over the next five years, says the New York Times. The Wall Street Journal adds that GE chief Jeffrey Immelt said that these funds are "250 million real dollars" and that the companies think they will be helped indirectly by the government stimulus package. Also as part of this, GE will sell the Intel Health Guide that helps patients monitor their health at home and send that information to their physicians. GE also makes a product called QuietCare that uses motion sensors to track patients' daily activities to look for abnormalities that may indicate a fall or other health problems. "Health care has to go efficiently into the home, to enable elders to age in place with dignity," says Louis Burns, the general manager of Intel's digital health group.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.